Biosimilars for inflammatory arthritis have been a revolution in improving quality of life and prolonging healthy life by years. If you have doubts or just want to know more you may be interested.
Every new batch of an originator biologic is a biosimilar of itself. A biosimilar by a different company is approved only after extensive evaluation by numerous national health agencies around the world. Think of a biosimilar as a biogeneric.
Live in Canada? Have #arthritis? Have questions about biosimilar transition policies? @Arthritis_ARC we know change can be difficult, so we're breaking down the facts on biosimilars in Ep.11 of the Arthritis Research Education Series: https://t.co/TsyeZ3nmhV @DianeLacaille
@maryadevera@UBC@Arthritis_ARC @UBCGradSchool @_vickicheng Congratulations Mary. You have achieved so much and made such a difference to patients. Bravo.
Senator Pat did incredible things for Canada both as a Minister of the Crown and then as a Senator. She also worked to promote awareness of and funding for arthritis, a set of at least 100 medical diseases which did not get the attention she felt they deserved. Bravo bravo Pat
The Honourable Pat Carney, founding Board member of @Arthritis_ARC is recognized today with all flags at half-mast on the Peace Tower in Ottawa and all Government of Canada buildings, the BC Parliament, and all establishments on Saturna Island. Learn More: https://t.co/SitBEoQSdg
The Honourable Pat Carney, founding Board member of @Arthritis_ARC is recognized today with all flags at half-mast on the Peace Tower in Ottawa and all Government of Canada buildings, the BC Parliament, and all establishments on Saturna Island. Learn More: https://t.co/SitBEoQSdg
Thank you @ACEJointHealth for helping us spread the word about this important #ArthritisResearch to help change how #arthritis care is delivered for people living with inflammatory types of arthritis.
New #ArthritisResearch aims to understand how rheumatology research may be missing information due to differences in health outcomes due to inequities such as age, gender identity, location, education, or other factors.
Learn More https://t.co/xCWZuUdnvE
@maryadevera@aavina100
#ArthritisResearch will explore healthcare system costs and impacts on families of children living with #Arthritis. This includes financial, education, employment, productivity, well-being and quality of life.
Learn more: https://t.co/3cpu6kKqRd
We’re thrilled to welcome Dr. @Amy_Lang as our keynote speaker for Putting Patients First 2023!
Amy is the executive director of #PatientOrientedResearch at @CIHR_IRSC. She leads #SPOR and other CIHR #POR initiatives. Hear her talk on October 24. #PPF23
https://t.co/IA4gPK1fYq
The Lohn Foundation has been a lead supporter of Arthritis Research Canada from day one. They have helped alter the lives of millions with arthritis around the world through research. Thank you so much.
We are thrilled to announce Lohn Foundation as a 2023 ARThritis Soirée Diamond Sponsor. Thank you for supporting life-changing #ArthritisResearch https://t.co/51hYWZWhFf
This Project Grant wound not be possible without the outstanding leadership of Nominated PI Dr. Teresa Liu-Ambrose @UBC_CogMobLab @UBC_PT@Aging_SMART 🙏
Problem: Rheumatologist follow-up appointments are scheduled at fixed intervals. Makes urgent need care difficult.
Research: We're creating a model of delivering care to accommodate specific needs. #ArthritisResearch@cehbarbe@DianeLacaille
Learn more https://t.co/ifQy3oc8IP